Imperva (IMPV) Tops Q1 EPS by 13c

Go back to Imperva (IMPV) Tops Q1 EPS by 13c

Imperva (IMPV) PT Raised to $57 at Imperial Capital Following 1Q Beat

May 8, 2017 10:45 AM EDT

Imperial Capital raised its price target on Imperva (NASDAQ: IMPV) to $57.00 (from $55.00) while maintaining a Outperform rating. IMPV reported 1Q revenue of $72.3mn and adjusted EPS of $0.09, compared with the Street's previous revenue estimates of $68.2mn and adjusted net loss per share estimates of... More